Page results
-
Our neonatal service is a recognised centre of excellence caring for acutely ill and preterm babies from our local area and beyond.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
This page has been written to answer some common questions about Tofersen treatment for patients, as well as their caregivers and families.
-
A surgical operation normally carried out to correct a blocked nasal passage may help patients who lost their sense of smell after contracting a COVID-19 infection, according to new research from UCLH.
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
This page explains what FACETS is and how it can help you.
File results
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease
-
FOI/2022/0451 - Patient information leaflets
-
FOI/2022/0454 - Temporary staff waiting list initiative and overtime spend
-
FOI/2022/0456 - Treatment of renal cell carcinoma
-
FOI/2022/0459 - Interpreters and translation services
-
FOI/2022/0465 - Treatment of dermatological conditions